5-Lipoxygenase modulates colitis through the regulation of adhesion molecule expression and neutrophil migration

Laboratory Investigation

Volumn 85, Issue 6, 2005, Pages 808-822

  Cuzzocrea, Salvatore ^a   Rossi, Antonietta ^b   Mazzon, Emanuela ^a   Di Paola, Rosanna ^a   Genovese, Tiziana ^a   Muià, Carmelo ^a   Caputi, Achille P ^a   Sautebin, Lidia ^b  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

5 Lipoxygenase; Adhesion molecules; Dinitrobenzene sulfonic acid; Neutrophil infiltration

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; BENZENESULFONIC ACID DERIVATIVE; CELL ADHESION MOLECULE; DINITROBENZENESULFONIC ACID; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 8; LEUKOTRIENE; MYELOPEROXIDASE; PADGEM PROTEIN; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; ZILEUTON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLON INJURY; COLON MUCOSA; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; EXPERIMENTAL MODEL; HEMORRHAGIC COLITIS; IMMUNOHISTOCHEMISTRY; INFLAMMATORY DISEASE; INTESTINE NECROSIS; KNOCKOUT MOUSE; LEUKOCYTE MIGRATION; MOUSE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TISSUE DISTRIBUTION; WEIGHT REDUCTION; WILD TYPE;

ANIMALS; ARACHIDONATE 5-LIPOXYGENASE; CHEMOTAXIS, LEUKOCYTE; COLITIS; DIARRHEA; DINITROFLUOROBENZENE; GENE EXPRESSION REGULATION; INTERCELLULAR ADHESION MOLECULE-1; MICE; MICE, KNOCKOUT; NEUTROPHILS; PEROXIDASE; VASCULAR CELL ADHESION MOLECULE-1;

EID: 20444376222     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1038/labinvest.3700276     Document Type: Article

References (76)

1. Cuzzocrea S. Emerging biotherapies for inflammatory bowel disease. Expert Opin Emerg Drugs 2003;8:339-347.
2. Elson CO. Experimental models of intestinal inflammation: new insights into mechanisms of mucosal homeostasis. In: Ogro PL, Lamm ME, Bienenstock J, Mestecky J, Strober W, McGhee JR (eds). Mucosal Immunology. Academic Press: San Diego, 1999, pp 1007-1024.
3. Snapper SB, Rosen FS, Mizoguchi E, et al. Wiskott-Aldrich syndrome protein-deficient mice reveal a role for WASP in T but not B cell activation. Immunity 1998;9:81-91.
4. Matsumoto S, Okabe Y, Setoyama H, et al. Inflammatory bowel disease-like enteritis caecitis in a senescence accelerated mouse P1/Yit strain. Gut 1998;43:71-78.
5. Blumberg RS, Saubermann LJ, Strober W. Animal models of mucosal inflammation and their relation to human inflammatory bowel disease. Curr Opin Immunol 1999;11:648-656.
6. Cuzzocrea S, McDonald MC, Mazzon E, et al. The tyrosine kinase inhibitor tyrphostin AG 126 reduced the development of colitis in the rat. Lab Invest 2000;80:1439-1453.
7. Mazzon E, Puzzolo D, Caputi AP, et al. Role of IL-10 in hepatocyte tight junction alteration in mouse model of experimental colitis. Mol Med 2002;8:353-366.
8. Henderson Jr WR. The role of leukotrienes in inflammation. Ann Intern Med 1994;121:684-697.
9. Dahlen SE, Bjork J, Hedqvist P, et al. Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response. Proc Natl Acad Sci USA 1981;78:3887-3891.
10. Dahlen SE, Hedqvist P, Hammarstrom S, et al. Leukotrienes are potent constrictors of human bronchi. Nature 1980;288:484-486.
11. Drazen JM, Austen KF. Leukotrienes and airway responses. Am Rev Respir Dis 1987;136:985-998.
12. Lewis RA, Austen KF, Soberman RJ. Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases. N Engl J Med 1990;323:645-655.
13. McIntyre TM, Zimmerman GA, Prescott SM. Leukotrienes C4 and D4 stimulate human endothelial cells to synthesize platelet-activating factor and bind neutrophils. Proc Natl Acad Sci USA 1986;83:2204-2208.
14. Patel KD, Zimmerman GA, Prescott SM, et al. Oxygen radicals induce human endothelial cells to express GMP-140 and bind neutrophils. J Cell Biol 1991;112:749-759.
15. Ratych RE, Chuknyska RS, Burkley GB. The primary localisation of free radical generation after anoxia/reoxygenation in isolated endothelial cells. Surgery 1987;102:122-131.
16. Bevilacqua MP, Stengelin S, Gimbrone Jr MA, et al. Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science 1989;243:1160-1165.
17. Hickey MJ, Kanwar S, McCafferty DM, et al. Varying roles of E-selectin and P-selectin in different microvascular beds in response to antigen. J Immunol 1999;162:1137-1143.
18. Bullard DC, Kunkel EJ, Kubo H, et al. Infectious susceptibility and severe deficiency of leukocyte rolling and recruitment in E-selectin and P-selectin double mutant mice. J Exp Med 1996;183:2329-2336.
19. Kunkel EJ, Ley K. Distinct phenotype of E-selectin-deficient mice. E-selectin is required for slow leukocyte rolling in vivo. Circ Res 1996;79:1196-1204.
20. Ley K, Allietta M, Bullard DC, et al. Importance of E-selectin for firm leukocyte adhesion in vivo. Circ Res 1998;83:287-294.
21. Milstone DS, Fukumura D, Padgett RC, et al. Mice lacking E-selectin show normal numbers of rolling leukocytes but reduced leukocyte stable arrest on cytokine-activated microvascular endothelium. Microcirculation 1998;5:153-171.
22. Keelan ET, Harrison AA, Chapman PT, et al. Imaging vascular endothelial activation: an approach using radiolabeled monoclonal antibodies against the endothelial cell adhesion molecule E-selectin. J Nucl Med 1994;35:276-281.
23. Picker LJ, Kishimoto TK, Smith CW, et al. ELAM-1 is an adhesion molecule for skin-homing T cells. Nature 1991;349:796-799.
24. Lorant DE, Topham MK, Whatley RE, et al. Inflammatory roles of P-selectin. J Clin Invest 1993;92:559-570.
25. Butcher EC. Specificity of leukocyte-endothelial interactions and diapedesis: physiologic and therapeutic implications of an active decision process. Res Immunol 1993;144:695-698.
26. Wertheimer SJ, Myers CL, Wallace RW, et al. Intercellular adhesion molecule-1 gene expression in human endothelial cells. J Biol Chem 1992;267:12030-12035.
27. Hulkower KI, Pollock JS, Walsh RE, et al. Leukotrienes do not regulate nitric oxide production in RAW 264.7 macrophages. Prostaglandins Leukot Essent Fatty Acids 1996;55:45-49.
28. Marotta P, Sautebin L, Di Rosa M. Modulation of the induction of nitric oxide synthase by eicosanoids in the murine macrophage cell line J774. Br J Pharmacol 1992;107:640-641.
29. Singh VP, Patil CS, Kulkarni SK. Effect of 5-lipoxygenase inhibition on events associated with inflammatory bowel disease in rats. Indian J Exp Biol 2004;42:667-673.
30. Hendel J, Ahnfelt-Ronne I, Nielsen OH. Expression of 5-lipoxygenase mRNA is unchanged in the colon of patients with active inflammatory bowel disease. Inflamm Res 2002;51:423-426.
31. Roberts WG, Simon TJ, Berlin RG, et al. Leukotrienes in ulcerative colitis: results of a multicenter trial of a leukotriene biosynthesis inhibitor, MK-591. Gastroenterology 1997;112:725-732.
32. Hawkey CJ, Dube LM, Rountree LV, et al. A trial of zileuton versus mesalazine or placebo in the maintenance of remission of ulcerative colitis. The European Zileuton Study Group For Ulcerative Colitis. Gastroenterology 1997;112:718-724.
33. Hillingso J, Kjeldsen J, Laursen LS, et al. Blockade of leukotriene production by a single oral dose of MK-0591 in active ulcerative colitis. Clin Pharmacol Ther 1995;57:335-341.
34. Zingarelli B, Squadrito F, Graziani P, et al. Effects of zileuton, a new 5-lipoxygenase inhibitor, in experimentally induced colitis in rats. Agents Actions 1993;39:150-156.
35. Sturiale S, Barbara G, Qiu B, et al. Neutral endopeptidase (EC 3.4.24.11) terminates colitis by degrading substance P. Proc Natl Acad Sci USA 1999;96:11653-11658.
36. Lora L, Mazzon E, Billington D, et al. Effects of cyclosporin A on paracellular and transcellular transport of horseradish peroxidase in perfused rat livers. Dig Dis Sci 1997;42:514-521.
37. Wallace JL, Keenan CM, Gale D, et al. Exacerbation of experimental colitis by non-steroidal antinflammatory drugs is not related to elevate leukotriene B4 synthesis. Gastroenterology 1992;102:18-27.
38. Miller MJ, Thompson JH, Zhang XJ, et al. Role of inducible nitric oxide synthase expression and peroxynitrite formation in guinea pig ileitis. Gastroenterology 1995;109:1475-1483.
39. Mullane KM, Kraemer R, Smith B. Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J Pharmacol Methods 1985;14:157-167.
40. Kayali ZAZ, Haddad W, Holmes EW, et al. Barrett differential effects of T-cell activation on gastric and small bowel permeability in alcohol-consuming mice. Alcohol Clin Exp Res 2002;26:1436-1443.
41. Lauredo IT, Sabater JR, Ahmed A, et al. Mechanism of pyocyanin- and 1-hydroxyphenazine-induced lung neutrophilia in sheep airways. J Appl Physiol 1998;85:2298-2304.
42. La M, Cao TV, Cerchiaro G, et al. A novel biological activity for galectin-1 inhibition of leukocyte-endothelial cell interactions in experimental inflammation. Am J Pathol 2003;163:1505-1515.
43. Perretti M, Croxtall JD, Wheller SK, et al. Mobilizing lipocortin 1 in adherent human leukocytes downregulates their transmigration. Nat Med 1996;2:1259-1262.
44. Ford-Hutchinson AW, Bray MA, Doig MV, et al. Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature 1980;286:264.
45. Geng JG, Bevilacqua MP, Moore KL, et al. Rapid neutrophil adhesion to activated endothelium mediated by GMP-140. Nature 1990;343:757-760.
46. Lawrence MB, Spinger TA. Leukocytes roll on a selectin at physiologic flow rates: distinction from and prerequisite for adhesion through integrins. Cell 1991;65:859-873.
47. Davenpeck KL, Gauthier TW, Albertine KH, et al. Role of P-selectin in microvascular leukocyte-endothelial interaction in splanchnic ischemia-reperfusion. Am J Physiol 1994;267:H622-H630.
48. Farhood A, McGuire GM, Manning AM, et al. Intercellular adhesion molecule 1 (ICAM-1) expression and its role in neutrophil-induced ischemia-reperfusion injury in rat liver. J Leukoc Biol 1995;57:368-374.
49. Shreeniwas R, Koga S, Karakurum M, et al. Hypoxia-mediated induction of endothelial cell interleukin-1 alpha. An autocrine mechanism promoting expression of leukocyte adhesion molecules on the vessel surface. J Clin Invest 1992;90:2333-2339.
50. Luscinskas FW, Ding H, Lichtman AH. P-selectin and vascular cell adhesion molecule 1 mediate rolling and arrest, respectively, of CD4+ T lymphocytes on tumor necrosis factor alpha-activated vascular endothelium under flow. J Exp Med 1995;181:1179-1186.
51. Clark WM, Lauten JD, Lessov N, et al. Time course of ICAM-1 expression and leukocyte subset infiltration in rat forebrain ischemia. Mol Chem Neuropathol 1995;26:213-230.
52. Horie Y, Wolf R, Iyasaka M, et al. Leukocyte adhesion and hepatic microvascular responses to intestinal ischemia/reperfusion in rats. Gastroenterology 1996;111:666-673.
53. Gauthier TW, Davenpeck KL, Lefer AM. Nitric oxide attenuates leukocyte-endothelial interaction via P-selectin in splanchnic ischemia-reperfusion. Am J Physiol 1994;267:G562-G568.
54. Hawkins HK, Entman ML, Zhu JY, et al. Acute inflammatory reaction after myocardial ischemic injury and reperfusion. Development and use of a neutrophil-specific antibody. Am J Pathol 1996;148:1957-1969.
55. Furie MB, Tancinco MC, Smith CW. Monoclonal antibodies to leukocyte integrins CD11a/CD18 and CD11b/CD18 or intercellular adhesion molecule-1 inhibit chemoattractant-stimulated neutrophil transendothelial migration in vitro. Blood 1991;78:2089-2097.
56. Kukielka GL, Youker KA, Hawkins HK, et al. Regulation of ICAM-1 and IL-6 in myocardial ischemia: effect of reperfusion. Ann NY Acad Sci 1994;723:258-270.
57. 4 hydrolase-deficient mice. J Immunol 1999;163:6810.
58. Byrum RS, Goulet JL, Griffiths RJ, et al. Role of the 5-lipoxygenase-activating protein (FLAP) in murine acute inflammatory responses. J Exp Med 1997;185:1065.
59. Laursen LS, Naesdal J, Bukhave K, et al. Selective 5-lipoxygenase inhibition in ulcerative colitis. Lancet 1990;35:683-685.
60. Bertran X, Mane J, Fernandez-Banares F, et al. Intracolonic administration of zileuton, a selective 5-lipoxygenase inhibitor, accelerates healing in a rat model of chronic colitis. Gut 1996;8:899-904.
61. Holma R, Salmenpera P, Riutta A, et al. Acute effects of the cys-leukotriene-1 receptor antagonist, montelukast, on experimental colitis in rats. Eur J Pharmacol 2001;29:309-318.
62. Wallace JL, MacNaughton WK, Morris GP, et al. Inhibition of leukotriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease. Gastroenterology 1989;96:29-36.
63. Hollander D. Intestinal permeability, leaky gut, and intestinal disorders. Curr Gastroenterol Rep 1999;1:410-416.
64. Bjarnason I, Maxton D, Reynolds AP, et al. Comparison of four markers of intestinal permeability in control subjects and patients with coeliac disease. Scand J Gastroenterol 1994;29:630-639.
65. Jenkins RT, Jones DB, Goodacre RL, et al. Reversibility of increased intestinal permeability to 51Cr-EDTA in patients with gastrointestinal inflammatory diseases. Am J Gastroenterol 1987;82:1159-1164.
66. Zhang Y, Lee B, Thompson M, et al. Lactulosemannitol intestinal permeability test in children with diarrhea caused by rotavirus and cryptosporidium. Diarrhea Working Group, Peru J Pediatr Gastroenterol Nutr 2000;31:16-21.
67. Alam AN, Sarker SA, Wahed MA, et al. Enteric protein loss and intestinal permeability changes in children during acute shigellosis and after recovery: effect of zinc supplementation. Gut 1994;35:1707-1711.
68. 51Cr]EDTA in infectious diarrhea. Dig Dis Sci 1993;38:1651-1657.
69. 51Cr]EDTA intestinal permeability in children with cow's milk intolerance. J Pediatr Gastroenterol Nutr 1990;10:189-192.
70. Ukabam SO, Mann RJ, Cooper BT. Small intestinal permeability to sugars in patients with atopic eczema. Br J Dermatol 1984;110:649-652.
71. Bjarnason I, MacPherson A, Hollander D. Intestinal permeability: an overview. Gastroenterology 1995;108:1566-1581.
72. Juby LD, Rothwell J, Axon AT. Lactulose/mannitol test: an ideal screen for celiac disease. Gastroenterology 1989;96:79-85.
73. Vogelsang H, Genser D, Wyatt J, et al. Screening for celiac disease: a prospective study on the value of non-invasive tests. Am J Gastroenterol 1995;90:394-398.
74. Hamilton I, Cobden I, Rothwell J, et al. Intestinal permeability in coeliac disease: the response to gluten withdrawal and single-dose gluten challenge. Gut 1982;23:202-210.
75. Wyatt J, Vogelsang H, Hubl W, et al. Intestinal permeability and the prediction of relapse in Crohn's disease. Lancet 1993;341:1437-1439.
76. D'Inca R, Di Leo V, Corrao G, et al. Intestinal permeability test as a predictor of clinical course in Crohn's disease. Am J Gastroenterol 1999;94:2956-2960.